Browsing Centre for Cancer Biomarkers & Biotherapeutics by Author "Aujayeb, A"
Now showing items 1-1 of 1
-
Phase 2 study to evaluate the novel mitochondrial PRX3 inhibitor, RSO-021, as an intrapleural monotherapy and in combination with IV paclitaxel in patients with malignant pleural effusion due to mesothelioma or another advanced solid tumor.
Dulloo, S; Lord, S; Fennell, DA; Thistlethwaite, F; Maskell, N; Popat, S; Blyth, KG; Szlosarek, PW; Aujayeb, A; Javed, SR (American Society of Clinical Oncology (ASCO), 2024-05-29)